UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Beta cells in type 1 diabetes: mass and function; sleeping or dead?

Diabetologia, 2019-04, Vol.62 (4), p.567-577

2019

Volltextzugriff (PDF)

100 years of insulin: celebrating the past, present and future of diabetes therapy

Nature medicine, 2021-07, Vol.27 (7), p.1154-1164

2021

Volltextzugriff (PDF)

370-OR: Proinflammatory Stress Activates Neutral Sphingomyelinase 2 Based Generation of Ceramide-Enriched ß-Cell Exosomes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Screening and Prevention of Type 1 Diabetes: Where Are We?

The journal of clinical endocrinology and metabolism, 2023-12, Vol.108 (12), p.3067-3079

2023

Volltextzugriff (PDF)

The role of beta-cell dysfunction in early type 1 diabetes

Current opinion in endocrinology, diabetes, and obesity, 2020-08, Vol.27 (4), p.215-224

2020

Volltextzugriff (PDF)

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Science translational medicine, 2021-03, Vol.13 (583)

2021

Volltextzugriff (PDF)

MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cells

Diabetologia, 2017-06, Vol.60 (6), p.1057-1065

2017

Volltextzugriff (PDF)

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes

Diabetes (New York, N.Y.), 2021-12, Vol.70 (12), p.2922-2931

2021

Volltextzugriff (PDF)

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (12), p.990

2023

Volltextzugriff (PDF)

Chewing the Fat: A Metabolic Role for Ldb1 Beyond the Pancreas?

Endocrinology (Philadelphia), 2017-05, Vol.158 (5), p.1113-1115

Sims, Emily K.

2017

Volltextzugriff (PDF)

731-P: The Effect of Abatacept upon Glucose and C-Peptide Endpoints at One Year of Treatment and on Follow-up

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders

Molecular endocrinology (Baltimore, Md.), 2015-11, Vol.29 (11), p.1535-1548

2015

Volltextzugriff (PDF)

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Diabetes (New York, N.Y.), 2022-04, Vol.71 (4), p.610-623

2022

Volltextzugriff (PDF)

Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes

Diabetologia, 2018-05, Vol.61 (5), p.1124-1134

2018

Volltextzugriff (PDF)

Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes

Diabetes care, 2016-09, Vol.39 (9), p.1519-1526

2016

Volltextzugriff (PDF)

Beta cells in type 1 diabetes: mass and function; sleeping or dead?

Diabetologia, 2019-04, Vol.62 (4), p.567-577

2019

Volltextzugriff (PDF)

Immune checkpoints and pancreatic beta cell dysfunction in HIV

AIDS (London), 2024-09, Vol.38 (11), p.1725-1727

2024

Volltextzugriff (PDF)

High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment

Diabetologia, 2023-12, Vol.66 (12), p.2283-2291

2023

Volltextzugriff (PDF)

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells

Blood, 2021-02, Vol.137 (6), p.775-787

2021

Volltextzugriff (PDF)

Biomarkers of islet beta cell stress and death in type 1 diabetes

Diabetologia, 2018-11, Vol.61 (11), p.2259-2265

2018

Volltextzugriff (PDF)

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies

Diabetes care, 2023-05, Vol.46 (5), p.1098-1105

2023

Volltextzugriff (PDF)

Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (12), p.980

2023

Volltextzugriff (PDF)

Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function

PloS one, 2018-05, Vol.13 (5), p.e0197080

2018

Volltextzugriff (PDF)

Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals

The journal of clinical endocrinology and metabolism, 2024-07, Vol.109 (8), p.2116-2123

2024

Volltextzugriff (PDF)

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Diabetes care, 2022-02, Vol.45 (2), p.311-318

2022

Volltextzugriff (PDF)

1 – 25 von 413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(353)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(409)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(34)
Alzheimer's & Dementia
(22)
Blood
(14)
Diabetes Care
(14)
Journal Of Hepatology
(13)
Diabetologia
(11)
Circulation
(9)
Mmwr. Morbidity And Mortality Weekly Report
(8)
Morbidity And Mortality Weekly Report
(8)
Molecular And Cellular Biology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Beta cells in type 1 diabetes: mass and function; sleeping or dead?

100 years of insulin: celebrating the past, present and future of diabetes therapy

370-OR: Proinflammatory Stress Activates Neutral Sphingomyelinase 2 Based Generation of Ceramide-Enriched ß-Cell Exosomes

Screening and Prevention of Type 1 Diabetes: Where Are We?

The role of beta-cell dysfunction in early type 1 diabetes

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cells

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

Chewing the Fat: A Metabolic Role for Ldb1 Beyond the Pancreas?

731-P: The Effect of Abatacept upon Glucose and C-Peptide Endpoints at One Year of Treatment and on Follow-up

Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes

Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes

Beta cells in type 1 diabetes: mass and function; sleeping or dead?

Immune checkpoints and pancreatic beta cell dysfunction in HIV

High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells

Biomarkers of islet beta cell stress and death in type 1 diabetes

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies

Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function

Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Suchergebnisse filtern